Cannabis and Hemp Industry Investment News
FSD Pharma said it will provide further updates to its shareholders in the coming weeks FSD Pharma Inc has announced the appointment of Anthony Durkac...
Bashir, a former general manager of Dubai-based business conglomerate Al Batha group, has more than 14 years of experience in strategic management and...
The nominees of the concerned group, led by Anthony Durkacz and Zeeshan Saeed, were elected At a meeting of the board following the shareholder meetin...
The proposed design is a randomized and double-blind trial of 200 dogs that will compare FSD201 dosed twice daily to a placebo for the treatment of ca...
The company noted that Coyle joined FSD Pharma as corporate controller in 2020 and has 15 years of executive business experience as a finance leader i...
FSD Pharma Inc (NASDAQ:HUGE) (CSE:HUGE) (FRA:0K9A) CEO Raza Bokhari talks to Proactive about the group's upcoming shareholder meeting on May 14, inten...
Under the agreement, Innovet granted the company a license to use ultra-micro PEA to develop the drugs The agreement grants FSD Pharma an ex...
The company said it expects to use any net proceeds of the offering to finance future growth opportunities, including acquisitions and investments, to...
The trial involves 352 patients to assess the efficacy and safety of FSD201 together with standard of care (SOC) compared to SOC alone The trial's pri...
As reported previously, the biotech has received the green light from the FDA to initiate the study to treat 352 hospitalized patients The group's ope...
Inc () (CSE:HUGE.CN) CEO Raza Bokhari tells Proactive the biopharma group is fully funded to continue progress on its Phase 2 study to treat hospitali...
Focused solely on lead anti-inflammatory drug FSD-201 Plans Phase 2 study of drug known as micro PEA in October 2020 Raises some $40 million in financ...
The biotech said the FDA has authorized a randomized, controlled, multicenter study on 352 patients FSD Pharma is developing micro-PEA, or FSD-201 for...
What are you searching for? viewFSD Pharma Inc () (CSE:HUGE.CN) (FRA:0K9A) CEO Raza Bokhari tells Proactive the group has submitted an Investigational...
A glance at some of the day's highlights from the Proactive Investors US and Canada newswires Ltd () (), the cyber security and privacy solutions prov...
A glance at some of the day's highlights from the Proactive Investors US and Canada newswires Aequus Pharmaceuticals Inc () () is getting ready to fil...
A glance at some of the day's highlights from the Proactive Investors US and Canada newswires Inc () (CSE:HUGE.CN) (FRA:0K9A) announced on Monday that...
The biotech said that the study is expected to be conducted at 25 to 30 hospitals in North America FSD Pharma is developing micro-PEA, or FSD-201 for ...
What are you searching for? viewFSD Pharma Inc (NASDAQ:HUGE) () CEO Raza Bokhari tells Proactive it has closed US$10 million in a registered direct of...
What are you searching for? viewFSD Pharma Investors can purchase up to 2,762,430 Class B subordinate voting shares and warrants to buy 1,381,215 shar...
